Eversept Partners, LP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 73 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$1,549,322
-25.7%
371,540
-7.5%
0.12%
-10.5%
Q4 2021$2,083,993
-20.1%
401,540
+0.9%
0.13%
-26.5%
Q3 2021$2,607,385
-17.0%
398,074
-15.9%
0.18%
-13.4%
Q2 2021$3,141,211
+126.7%
473,074
+205.2%
0.21%
+28.2%
Q4 2020$1,385,530
-66.5%
154,981
-40.0%
0.16%
-71.3%
Q2 2020$4,141,511
+229.2%
258,360
+23.0%
0.57%
+81.5%
Q1 2020$1,257,978210,0130.31%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders